Cargando…

Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study

BACKGROUND: Inflammatory arthritides including rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS) are associated with increased risk of cardiovascular disease. This process may be driven by systemic inflammation, and the use of tumour necrosis factor (TNF) inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Joshua L., Sinnathurai, Premarani, Buchbinder, Rachelle, Hill, Catherine, Lassere, Marissa, March, Lyn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081907/ https://www.ncbi.nlm.nih.gov/pubmed/30086795 http://dx.doi.org/10.1186/s13075-018-1669-x

Ejemplares similares

Cardiovascular risk management in rheumatoid and psoriatic arthritis: online survey results from a national cohort study
por: Sinnathurai, Premarani, et al.
Publicado: (2018)

Mortality estimates and excess mortality in rheumatoid arthritis
por: Black, Rachel J, et al.
Publicado: (2023)

Attitudes of Australians with inflammatory arthritis to biologic therapy and biosimilars
por: Quinlivan, Alannah, et al.
Publicado: (2022)

Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry
por: Black, Rachel J., et al.
Publicado: (2017)

Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: an update from the Australian Rheumatology Association Database (ARAD) prospective cohort study
por: Staples, Margaret P., et al.
Publicado: (2019)

Vaccination Rates, Perceptions, and Information Sources Used by People With Inflammatory Arthritis
por: Lyon, Andrea, et al.
Publicado: (2023)

Patterns of biologic and targeted-synthetic disease-modifying antirheumatic drug use in rheumatoid arthritis in Australia
por: Fletcher, Ashley, et al.
Publicado: (2022)

Oral Complementary Medicine Use among People with Inflammatory Arthritis: An Australian Rheumatology Association Database Analysis
por: Fletcher, Ashley, et al.
Publicado: (2020)

Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: analysis of the Australian Rheumatology Association Database (ARAD) prospective cohort study
por: Buchbinder, Rachelle, et al.
Publicado: (2015)

Baseline Comorbidities in a Population-Based Cohort of Rheumatoid Arthritis Patients Receiving Biological Therapy: Data from the Australian Rheumatology Association Database
por: Briggs, Andrew M., et al.
Publicado: (2009)

Trajectories of self-reported pain-related health outcomes and longitudinal effects on medication use in rheumatoid arthritis: a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
por: Pisaniello, Huai Leng, et al.
Publicado: (2023)

Ankylosing Spondylitis Patients Commencing Biologic Therapy Have High Baseline Levels of Comorbidity: A Report from the Australian Rheumatology Association Database
por: Oldroyd, John, et al.
Publicado: (2009)

Magnetic resonance imaging in psoriatic arthritis: a review of the literature
por: McQueen, Fiona, et al.
Publicado: (2006)

Perceptions towards biologic and biosimilar therapy of patients with rheumatic and gastroenterological conditions
por: Khoo, Thomas, et al.
Publicado: (2022)

Perspectives of Glucocorticoid Use in Patients with Rheumatoid Arthritis
por: Venter, Gabriella, et al.
Publicado: (2021)

Global low back pain prevalence and years lived with disability from 1990 to 2017: estimates from the Global Burden of Disease Study 2017
por: Wu, Aimin, et al.
Publicado: (2020)

Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout
por: Hansildaar, Romy, et al.
Publicado: (2021)

Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
por: Suruki, Robert Y, et al.
Publicado: (2022)

Hydroxychloroquine and Cardiovascular Events in Patients with Rheumatoid Arthritis
por: Cordova Sanchez, Andres, et al.
Publicado: (2022)

Cardiovascular Risk in Systemic Inflammatory Arthritis
por: Atzeni, Fabiola, et al.
Publicado: (2023)

Low serum IGF1 is associated with hypertension and predicts early cardiovascular events in women with rheumatoid arthritis
por: Erlandsson, Malin C., et al.
Publicado: (2019)

General Practitioner Management of Shoulder Pain in Comparison with Rheumatologist Expectation of Care and Best Evidence: An Australian National Survey
por: Buchbinder, Rachelle, et al.
Publicado: (2013)

Cardiovascular Disease and Cardiac Imaging in Inflammatory Arthritis
por: Madenidou, Anastasia-Vasiliki, et al.
Publicado: (2023)

Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients
por: Peluso, Rosario, et al.
Publicado: (2018)

Similar risk of cardiovascular events in idiopathic inflammatory myopathy and rheumatoid arthritis in the first 5 years after diagnosis
por: Párraga Prieto, Cristina, et al.
Publicado: (2020)

Shoulder range of movement in the general population: age and gender stratified normative data using a community-based cohort
por: Gill, Tiffany K., et al.
Publicado: (2020)

Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre Study
por: Ruscitti, Piero, et al.
Publicado: (2017)

Psoriasis, Cardiovascular Events, and Biologics: Lights and Shadows
por: Caiazzo, Giuseppina, et al.
Publicado: (2018)

Is blood pressure reduction a valid surrogate endpoint for stroke prevention? an analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and the biomarker-surrogacy (BioSurrogate) evaluation schema (BSES)
por: Lassere, Marissa N, et al.
Publicado: (2012)

Biologic Agents—A Panacea for Inflammatory Arthritis or Not?
por: Ninan, J., et al.
Publicado: (2009)

Global, regional, and national burden of neck pain in the general population, 1990-2017: systematic analysis of the Global Burden of Disease Study 2017
por: Safiri, Saeid, et al.
Publicado: (2020)

Modified Delphi study to identify priority clinical questions for the Australian living guidelines for the management of Juvenile Idiopathic Arthritis
por: Tiller, Georgina, et al.
Publicado: (2022)

Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
por: Pina Vegas, Laura, et al.
Publicado: (2021)

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)

Rates of Cardiovascular Disease and Major Adverse Cardiovascular Events in Patients With Psoriatic Arthritis Compared to Patients Without Psoriatic Arthritis
por: Li, Lin, et al.
Publicado: (2015)

Gynaecological Malignancies Among a Representative Population of Batticaloa, Sri Lanka
por: Thirukumar, Markandu, et al.
Publicado: (2021)

Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort study
por: Rungapiromnan, W., et al.
Publicado: (2019)

Is it time to reconsider the indications for surgery in patients with tennis elbow?
por: Karjalainen, Teemu, et al.
Publicado: (2023)

LIFE EVENTS AND CARDIOVASCULAR DISEASE EVENTS: THE STUDY OF WOMEN'S HEALTH ACROSS THE NATION
por: Koffer, Rachel, et al.
Publicado: (2022)

Rheumatoid arthritis, as a clinical disease, but not rheumatoid arthritis-associated autoimmunity, is linked to cardiovascular events
por: Gouze, Hélène, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o927j9hq36l0hcg2uq5fuiq93d